Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, PTC Therapeutics (PTCT) has a market cap of $3.70 billion USD. According to our data, PTC Therapeutics is ranked No.3042 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $3.70 B |
6.34%
|
| Dec 31, 2024 | $3.48 B |
63.79%
|
| Dec 29, 2023 | $2.13 B |
-27.80%
|
| Dec 30, 2022 | $2.94 B |
-4.17%
|
| Dec 31, 2021 | $3.07 B |
-34.74%
|
| Dec 31, 2020 | $4.71 B |
27.07%
|
| Dec 31, 2019 | $3.70 B |
39.95%
|
| Dec 31, 2018 | $2.65 B |
105.76%
|
| Dec 29, 2017 | $1.29 B |
52.89%
|
| Dec 30, 2016 | $0.84 B |
-66.33%
|
| Dec 31, 2015 | $2.50 B |
-37.42%
|
| Dec 31, 2014 | $3.99 B |
205.07%
|
| Dec 31, 2013 | $1.31 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
USA
|
 Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
USA
|
 Ultragenyx
RARE
|
$3.32 B |
0.000 M
|
USA
|
 Amicus Therapeutics
FOLD
|
$2.12 B |
-0.000 M
|
USA
|
 bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
USA
|
 CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
Switzerland
|
 Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
USA
|
 Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
USA
|
 Rocket Pharmaceuticals
RCKT
|
$0.70 B |
0.000 M
|
USA
|
 Solid Biosciences
SLDB
|
$0.21 B |
0.000 M
|
USA
|
| Market Cap | = | PTCT Stock Price | * | PTCT Shares Outstanding |
| = | $46.94 | * | 78.87 M | |
| = | $3.70 B |